A good part of September was spent in Asia at our gatherings in Shanghai and Tokyo at JLabs and IBM respectively. Over the last 5 years, we have been hosting these events all around the globe but this was a first for HealthXL and we thoroughly enjoyed it while also learning lots of new things.
There are 3.3 million unique genes in the human gut, 150 times more genes than the human genome - basically, we are more microbiome than we are human. This week we take a dive into the flourishing microbiome space and digital interventions supporting its scale to supercharge personalized healthcare.
We recently released our Q1 report on Virtual Health Assistants (VHAs). As part of the report, we carried out a survey on consumers and clinicians. In this weeks blog, we examine the results of our survey to gain an insight into consumer and clinician awareness, adoption, and trust in VHAs.
Primary care is the healthcare provided in the community for people making an initial approach to a medical practitioner or clinic for advice or treatment and it's undergoing major change internationally. In this blog we explore how digital can support and improve the delivery of care.
Our report on Virtual Health Assistants (VHA). The report looks at the investment landscape, clinical evidence, and regulatory environment for VHAs, and also explores end-user feedback and case studies looking at both the positives and negatives of VHAs.
The Global Gathering hosted by Northwell Health welcomed over 80 attendees, convening over curated debates with from healthcare leaders. The event brought together members, collaborators, innovators & entrepreneurs. People with ideas, resources and desire to contribute to the evolution of healthcare
Best practices for collaboration between corporates and startups. The 12 commandments are a product of inspirational discussions with a great group of very experienced people.
In this weeks blog, we take a look at how the unprecedented public interest in the Theranos case has impacted the digital health space, sparking questions around digital health valuations, due diligence, and clinical evidence.
There is a modern day gold rush happening in China. The environment is prime for digital health and healthcare innovation, something pharma decision makers know well - an awareness that is now being explicitly demonstrated. Here is an introductory insight into why the Chinese market is appealing.
Few people trust their health insurance company. The numbers are unsurprising. According to a 2017 Revive Health survey 79% of consumers trust their doctors whilst only 69% reported trusting their insurers.This week we take a look at the emerging next gen payers.
In this weeks blog, we explore why the ‘gold standard’ RCT in its current form is not necessarily the perfect fit for evaluating digital health solutions, and what some appropriate alternatives may be.
This week we outline what can we learn from digitally enabled patient communities, where diverse stakeholder groups can benefit, where activity is gaining momentum and what needs to happen for patient communities to have a lasting impact.
The frenetic M&A activity in healthcare is rather disorienting and difficult to keep up with. We’ve rounded up the key themes we are seeing and what this may mean for all of us.
What does a ‘good’ digital health solution look like? Is ‘good’ even enough when it comes to putting a digital solution in a patient’s hands? Read on for an insight into the new NICE Guidelines for encouraging informed partnerships and collaboration between digital health innovators and the NHS.
2018 was quite the year for M&A activity in healthcare. Some big announcements made waves such as the Amazon-PillPack, Roche-Flatiron, Cigna-Express Scripts, CVS-Aetna, ResMed-Propeller deals, there were hundreds of smaller ones too. We dig into what the ResMed - Propeller deal could mean for all.
We’ve put together a list of 8 digital health trends to keep on your radar in 2019 based on everything we’ve read and heard from our members, advisors, friends at start-ups, and investors, coupled with data from the HealthXL platform to bring you a perfect mix of subjective and objective data.
We are at the begining of a new chapter in digital health and plan to excede your expectations in 2019. Join the tribe and be at forefront of innovation and change in healthcare.
We look back at the highlights from HealthXL in 2018. Events we hosted around the world, reports we published with expert insight as well as webinars, blogs and staying ahead of trends throughout the year.
The best of digital health 2018 drew factors from trending topics, community interest and positive feedback where content provided insights that benefited our readers in their relevant fields.
We're rounding up the most popular posts of the year as we bid adieu to 2018. We have analysed key trends and member favourites so we can bring you more great content next year.
The new wave in the industry is Digital Therapeutics (DTx). The term came into existence under the premise that mobile software can be effective medical treatments. DTx certainly seem to exhibit a superiority above all the 'banal' digital health solutions, but is the promise real?
This week we take look at the implications of electronic patient reported outcome (ePROs) interventions and some notable partnerships and evidence behind these solutions. Is this the future of routine cancer care? We think so. Read on to find out why:
In this week’s blog, we look at how digital health can play a role in clinical trials - from patient recruitment, to helping patients control their own trial experience, to collecting more regular and more accurate data from the trials.
Prescription and Reimbursement: Navigating Uncharted Waters in Digital Therapeutics. Recorded in September 2018.
Silicon Valley is known around the world as the center for technology innovation. In this blog post, we have used investment as a proxy for innovation to understand if maybe Silicon Valley has overstayed its welcome and is now paving the way for other tech innovation hubs in the USA and abroad.